Quick Answer
Larimar Therapeutics, Inc. reported Common Stock Shares Outstanding of 83.09 million shares for the year ending 2025.
- Larimar Therapeutics, Inc. showed an increase of +30.2% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Larimar Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Larimar Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 11,291.7%.
- Historical annual values: Fiscal year 2025: 83.09 million shares | Fiscal year 2024: 63.82 million shares | Fiscal year 2023: 43.91 million shares | Fiscal year 2022: 43.27 million shares | Fiscal year 2021: 17.71 million shares | Fiscal year 2020: 15.37 million shares | Fiscal year 2019: 6.09 million shares | Fiscal year 2018: 37.29 million shares | Fiscal year 2017: 27.49 million shares | Fiscal year 2016: 27.33 million shares | Fiscal year 2015: 27.24 million shares | Fiscal year 2014: 22.88 million shares | Fiscal year 2013: 729,391 shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: